Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000921895-21-001638)

Filing Details

Accession Number:: 0000921895-21-001638
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-15 16:47:06
Reporting Period:: 2021-06-14

Accepted Time:: 2021-06-15 16:47:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1497504	Plx Pharma Inc.	PLXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1319551	J Michael Valentino	9 Fishers Lane Suite E Sparta NJ 07871	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-14	1,200	$12.44	487,890	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	400	$12.45	488,290	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	100	$12.45	488,390	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	100	$12.47	488,490	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	600	$12.47	489,090	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	300	$12.47	489,390	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	100	$12.49	489,490	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	5,080	$12.50	494,570	No	4	P	Direct
Common Stock	Acquisiton	2021-06-14	120	$12.51	494,690	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct